SCHEMBL14083918

SCHEMBL14083918

COc1ccccc1NC(=O)c1ccc(-c2ncccc2Cl)cn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ AHR P35869 1/20 0.61
▸ P4HTM Q9NXG6 1/20 0.55
▸ MAPT P10636 3/20 0.52
▸ IRAK4 Q9NWZ3 2/20 0.50
▸ RAB9A P51151 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ NPC1 O15118 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ GRM4 Q14833 1/20 0.48
▸ STAT3 P40763 1/20 0.48
▸ STAT1 P42224 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ GFER P55789 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ATR Q13535 1/20 0.47
▸ GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083476 0.87 KMT2A (0.59) KMT2AMEN1AHRP4HTMMAPT
SCHEMBL14083924 0.87 MCL1 (0.57) KMT2AMEN1P4HTMMAPTIRAK4
SCHEMBL14083035 0.83 POLB (0.58) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL14108041 0.82 HDAC1 (0.59) P4HTM
SCHEMBL14083936 0.82 GRM4 (0.66) KMT2AMEN1MAPTRAB9AALDH1A1
SCHEMBL14083998 0.82 KDM4E (0.62) MAPTRAB9ANPC1GRM4SMN1; SMN2
SCHEMBL14084015 0.82 SMN1; SMN2 (0.62) KMT2AMEN1P4HTMMAPTRAB9A
SCHEMBL14083047 0.82 MEN1 (0.51) KMT2AMEN1P4HTMMAPTIRAK4
SCHEMBL14083587 0.82 ALDH1A1 (0.53) KMT2AMEN1MAPTIRAK4RAB9A
SCHEMBL14083963 0.81 POLB (0.53) KMT2AMEN1MAPTRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 KMT2A 4272/4885MEN1 4218/4885AHR 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback